The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

CORRECTED-Five charged in U.S. with stealing secrets from GlaxoSmithKline

Thu, 21st Jan 2016 17:42

(In Jan. 20 item, corrects in 4th paragraph to show one oflisted companies incorporated in Delaware and two likely inChina)

By Bill Berkrot

Jan 20 (Reuters) - Five people, including two scientists whodid research for GlaxoSmithKline, were charged with ascheme to steal trade secrets from the British drugmaker forpotential sale in China, according to indictments announced bythe U.S. Attorney's Office in Philadelphia on Wednesday.

The indictments include charges of conspiracy to steal tradesecrets of Glaxo medicines, conspiracy to commit wire fraud,conspiracy to commit money laundering, theft of trade secrets,and wire fraud.

The stolen information on drugs for cancer and other seriousdiseases "potentially could be sold for millions of dollars torival pharmaceutical companies and it would also be usefulinformation for a start-up pharmaceutical company," thecomplaint said.

The alleged conspirators established three corporations, oneincorporated in Delaware, and two likely in China, all using thename Renopharma, to market and sell the stolen information thatcould be used to reproduce Glaxo products and drugs indevelopment, to competitors in China, according to thecomplaint.

One of the five, Yu Xue, is a senior-level manager andbiotechnology expert at a Glaxo research facility inPennsylvania with access to a wide array of trade secretinformation.

She is accused of emailing confidential information relatedto a dozen or more products to her personal email account andforwarding it to fellow "conspirators and others," and alsodownloading a substantial amount of Glaxo intellectual propertyto pass along as part of the alleged scheme.

A motion aimed at keeping Yu Xue detained that was filedearlier this month said she "stole millions, perhaps billions,of dollars' worth of trade secret and other confidentialinformation from her employer, GlaxoSmithKline, to resell inChina."

"Ms. Xue denies these allegations. She has pled not guiltyand intends to contest these charges vigorously in court," herattorney Peter Zeidenberg of Arent Fox said in an emailedstatement.

The others named were Lucy Xi, a former Glaxo scientist, TaoLi, Yan Mei and Tian Xue, who is Yu Xue's twin sister. Thesister was used to hide proceeds of the crime, according to thecomplaint.

All were arrested except for Mei, who is being sought byauthorities. Tao Li remains in custody, while the other threewere released on bail, according to a spokeswoman for the U.S.Attorney's office.

The alleged crimes took place between Jan. 1, 2012 and Dec.28, 2015, the complaint said.

Glaxo could not immediately be reached for comment. Thecriminal complaint says the company was aware of theinvestigation by the Federal Bureau of Investigation. (Reporting by Bill Berkrot and Nate Raymond)

Related Shares

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a...

2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U....

1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2% *

1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.